Testosterone and 5α-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines

Gynecological Endocrinology

Volumn 16, Issue 2, 2002, Pages 113-120

  Ortmann, J ^a   Prifti, S ^a   Bohlmann, M K ^a   Rehberger Schneider, S ^a   Strowitzki, T ^a   Rabe, T ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Androgen receptor; Androgens; Breast cancer; Breast cancer cell lines; Proliferation

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; ESTROGEN; ESTROGEN RECEPTOR; TESTOSTERONE;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 0036252154     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/gye.16.2.113.120     Document Type: Article

References (27)

1. Breast carcinoma aetiology: Current knowledge and new insights into the effects of reproductive and hormonal risk factors in black and white populations
2. Estrogen and the risk of breast cancer
3. Elevated serum estradiol and testosterone concentration are associated with a high risk for breast cancer
4. Endogenous hormone metabolism as an exposure marker in breast cancer chemoprevention studies
5. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk
6. Upregulation of L-plastin gene by testosterone in breast and prostate cancer cells: Identification of three cooperative androgen receptor-binding sequences
7. Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines
8. Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter
9. Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression
10. Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer
11. Tumour response and estrogen suppression in breast cancer patients treated with aromatase inhibitors
12. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding
13. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxic assays
14. Androgens induce divergent proliferative responses in human breast cancer cell lines
15. Steroid metabolism in the hormone dependent MCF-7 human breast carcinoma cell line and its two hormone resistant subpopulations MCF-7/LCC1 and MCF-7/LCC2
16. Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells
17. Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells
18. Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line
19. The estrogenic and antiestrogenic activities of androgens in female target tissues
20. A secret glycoprotein induced by estrogen in human breast cancer cell lines
21. Conjugated estrogens and breast cancer risk
22. Multiple steroid metabolic pathways in ZR-75-1 human breast cancer cells
23. Androgen regulation of prolactin-receptor gene expression in MCF-7 and MDA-MB-453 human breast cancer cells
24. Prolactin: The forgotten hormone of human breast cancer
25. Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: A new marker of steroid action in breast cancer
26. Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells
27. Androgens down-regulate bcl-2 protooncogene expression in ZR-75-1 human breast cancer cells